Nanomedicine promotes ferroptosis to inhibit tumour proliferation in vivo

miR-101–3p may play a therapeutic role in various tumours. However, its anti-tumour mechanism remains unclear, and a definitive strategy to treat tumour cells in vivo is lacking. The objective of this study was to investigate the inhibitory mechanism of miR-101–3p on tumour cells and to develop rele...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Yifeng, Niu, Gang, Yi, Hui, Li, Qingling, Wu, Zhiqiang, Wang, Jing, Yang, Juan, Li, Bo, Peng, Yuan, Liang, Ying, Wang, Weiwei, Peng, Zhenwei, Shuai, Xintao, Guo, Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Articles from the Special Issue on Redox Modulation of Cancer Heterogeneity, Therapeutic Resistance and Immunotherapy Efficacy; Edited by Dr. Anita Hjelmeland
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113035/
https://www.ncbi.nlm.nih.gov/pubmed/33674250
http://dx.doi.org/10.1016/j.redox.2021.101908

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113035/
https://www.ncbi.nlm.nih.gov/pubmed/33674250
http://dx.doi.org/10.1016/j.redox.2021.101908

Ejemplares similares